|
|
|
|
|
|
|
|
|
|
|
09.10.25 - 13:03
|
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress (GlobeNewswire EN)
|
|
|
DUBLIN, Oct. 09, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced the acceptance of a Novel Therapies Symposium Presentation at the 38th Annual European College of Neuropsychopharmacology Congress (ECNP) in Amsterdam, the Netherlands from October 11 – 14, where Professor Wiesław J. Cubała, MD, PhD, Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, will present long-term clinical data on the safety and efficacy from the open label extension (OLE) of a randomized, double-blind, placebo-controlled Phase 2b clinical trial with GH001 in patients with treatment-resistant depression (TRD) (GH001-TRD-201)....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02.10.25 - 02:03
|
Blue Matter stellt mit Eva Kersey einen neuen Partner ein und baut damit seine Kompetenzen in Europa weiter aus (Business Wire)
|
|
|
LONDON--(BUSINESS WIRE)--Blue Matter freut sich mitteilen zu können, Eva Kersey als Partner mit Sitz in London für das Unternehmen gewonnen zu haben. Eva ist dem Team von Blue Matter am 16. September offiziell beigetreten und bringt umfangreiche Erfahrungen in der strategischen Beratung von Kunden aus den Bereichen Pharmazie, Biotechnologie und Medizintechnik mit.
Eva ist seit 2007 für Kunden aus dem Bereich Life Sciences tätig. Sie startete ihre Beraterkarriere bei PHP (jetzt Teil von Accenture). Seitdem bekleidete sie Führungs- und Partnerpositionen bei IMS Consulting, IQVIA und ClearView Healthcare Partners. Über die Jahre konnte sie Beratungserfahrung entlang der gesamten Wertschöpfungskette sammeln, wobei ihr Schwerpunkt auf der Entwicklung funktionsübergreifender Strategien lag. Sie hat sich vor allem auf Therapie- und Franchise-Strategien, Portfoliooptimierung sowie Preis-, Zugangs- und Evidenzstrategien spezialisiert. Außerdem verfügt sie über umfassende Expertise in allen Aspekten der ...
|
|
|
01.10.25 - 15:06
|
Blue Matter Hires New Partner, Eva Kersey, Further Strengthening Capabilities in Europe (Business Wire)
|
|
|
LONDON--(BUSINESS WIRE)--Blue Matter is pleased to announce that Eva Kersey has joined the firm as a Partner based in London. Eva officially joined the Blue Matter team on September 16, bringing a broad base of strategic consulting experience across pharmaceutical, biotech, and medical technology clients.
Eva has been serving life science clients since 2007. She began her consulting career at PHP (now a part of Accenture). Since then, she has served in leadership and Partner-level positions at IMS Consulting, IQVIA, and ClearView Healthcare Partners. Over the years, her consulting experience has spanned the full value chain, focusing on cross-functional strategy development. She brings a particular specialization in therapy and franchise strategy, portfolio optimization, and pricing, access and evidence strategy. She also brings significant expertise in all aspects of commercial strategy development for clinical-stage, pre-launch assets.
“I'm extremely excited to join the Blue Matter team,” Eva said....
|
|
|
30.09.25 - 18:51
|
Remote Patient Monitoring Market Industry Report 2025-2035, with Profiles of BioTelemetry, Braster, LeewayHertz, LifeWatch, Masimo, Medtronic, Siemens Healthineers, and Transtek Medical - ResearchAndMarkets.com (Business Wire)
|
|
|
DUBLIN--(BUSINESS WIRE)--The "Remote Patient Monitoring Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Software, Application Area, Therapeutic Area, Product/Software Purpose, Type of Business Model, and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.
The global remote patient monitoring market is estimated to grow from USD 9.4 billion in 2025 to USD 88 billion by 2035, at a CAGR of 25% during the forecast period, till 2035.
Remote Patient Monitoring Market: Growth and Trends
Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. In fact, a recent report from the Center for Managing Chronic Disease at the University of Michigan reported that over 50% of the US population is affected by some form of chronic disease. Consequently, there is an urgent need for frequent monitoring to manage disease indications. However, some patients fail to report health ...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
